We are live on
!
Find out more
SELLAS Life Sciences
31 hedge funds and large institutions have $13.3M invested in SELLAS Life Sciences in 2021 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 9 increasing their positions, 3 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
250% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 4
200% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 3
147% more capital invested
Capital invested by funds: $5.37M → $13.3M (+$7.88M)
48% more funds holding
Funds holding: 21 → 31 (+10)
16% more call options, than puts
Call options by funds: $2.41M | Put options by funds: $2.07M
2.44% more ownership
Funds ownership: 7.85% → 10.29% (+2.4%)
Holders
31
Holders Change
+10
Holders Change %
+47.62%
% of All Funds
0.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
9
Reduced
3
Closed
4
Calls
$2.41M
Puts
$2.07M
Net Calls
+$332K
Net Calls Change
-$38K
Top Buyers
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.37M |
| 2 |
BlackRock
New York
|
+$1.24M |
| 3 |
Nomura Holdings
Tokyo,
Japan
|
+$1.08M |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$495K |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$424K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$877K |
| 2 |
Jane Street
New York
|
-$112K |
| 3 |
Squarepoint
New York
|
-$59K |
| 4 |
VF
Virtu Financial
New York
|
-$39.7K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$19K |
